Pfizer Gets Nod From FDA For Booster Shots For High-Risk Population
FDA Approves Pfizer Booster Shot For Select Population
The Food and Drug Administration has shown the green light for Pfizer booster shots. However, only a select group of the population is eligible for it. People above the age of 65 and people above 18 who are at high risk of contracting COVID will be eligible for the booster shot. This includes ‘health care workers, teachers and daycare staff, grocery workers and those in homeless shelters or prisons’. The booster shot will be administered to those people who have completed six months after taking the first and second doses.
Will Continue To Evaluate The Booster Shot, Says FDA Commissioner Janet Woodcock
FDA Commissioner Janet Woodcock is well aware that coronavirus is continuously mutating and changing. The scientists and medical experts are constantly studying it and it has paved the way for booster shots. Janet revealed the FDA would continue to evaluate the pandemic and the booster shot and keep the public updated. Furthermore, she said, “This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed.”